Rheumatoid Arthritis Medication Study Research Articles

THU0487 Identification of 131 Differential Gene Expression Profiles in Good Responders in the First Few Weeks after MTX Commencement: Results from the Rheumatoid Arthritis Methotrexate Study (RAMS)

BackgroundMethotrexate (MTX) is the DMARD of first choice in most patients with rheumatoid arthritis (RA). However, a significant minority (30-40%) of patients do not respond to MTX therapy. Gene expression...

AB0436 Patient acceptable symptom state in rheumatoid arthritis patients starting methotrexate correlates with age and patient reported outcomes

BackgroundThe patient acceptable symptom state (PASS) is a patient reported outcome used to identify the health state patients find acceptable or satisfactory. Limited data is available about the contribution of...

SAT0561 High Levels of Disease Activity and Psychological Distress Predict Sick Leave in Patients with Rheumatoid Arthritis Starting Treatment with Methotrexate.

BackgroundRheumatoid arthritis (RA) is known to have adverse consequences on those undertaking paid employment. Little is known about the association between psychological factors and these work related outcomes.ObjectivesTo establish whether...